CIK: 0001524362
Total reported value
—
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | OBDC | Blue Owl Capital Corporation | Stock-Financials | 19.41% | — | — | |
| 2 | BAND 0.5 04-01-28 | Bandwidth INC | Stock-Other | 15.50% | — | — | |
| 3 | ONTF | On24 INC | Stock-Other | 13.20% | -100.00% | EXIT | |
| 4 | RVNC 1.75 02-15-27 | Revance Therapeutics INC | Stock-Other | 11.58% | — | — | |
| 5 | INN 1.5 02-15-26 | Summit Hotel Properties | Stock-Other | 10.58% | — | +403.64% | |
| 6 | HP5A | Equity Commonwealth | Stock-Other | 8.14% | — | +103.19% | |
| 7 | IRWD 1.5 06-15-26 | Ironwood Pharmaceuticals | Stock-Other | 6.28% | — | +55.56% | |
| 8 | TVTX 2.5 09-15-25 | Travere Therapeutics INC | Stock-Other | 6.18% | — | — | |
| 9 | AXDX 5 12-15-26 | Accelerate Diagnostics | Stock-Other | 5.95% | — | +2.50% | |
| 10 | ESPR | Esperion Therapeutics INC | Stock-Other | 3.18% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | OBDC | Blue Owl Capital Corporation | +19.4% | NEW | New buy |
| 2 | RVNC 1.75 02-15-27 | Revance Therapeutics INC | +11.6% | NEW | New buy |
| 3 | INN 1.5 02-15-26 | Summit Hotel Properties | +8.8% | +403.64% | Add |
| 4 | TVTX 2.5 09-15-25 | Travere Therapeutics INC | +6.2% | NEW | New buy |
| 5 | ESPR | Esperion Therapeutics INC | +3.2% | NEW | New buy |
| 6 | IRWD 1.5 06-15-26 | Ironwood Pharmaceuticals | +2.9% | +55.56% | Add |
| 7 | ONTF | On24 INC | +2.1% | — | Unchanged |
| 8 | BAND 0.5 04-01-28 | Bandwidth INC | +2.1% | — | Unchanged |
| 9 | AXDX 5 12-15-26 | Accelerate Diagnostics | +0.6% | +2.50% | Add |
| 10 | LAB 5.25 12-01-24 | Standard Biotools INC | -3.3% | EXIT | Sold out |
| 11 | XMTR 1 02-01-27 | Xometry INC | -7.9% | EXIT | Sold out |
| 12 | ESPR 4 11-15-25 | Esperion Therapeutics | -13.7% | EXIT | Sold out |
| 13 | HP5A | Equity Commonwealth | -31.9% | +103.19% | Add |